| | Table of contents
Rev. OFIL·ILAPHAR vol.32 n.4 Madrid Oct./Dec. 2022  Press Release | | | | |
| Editorials | | | | | | · "OFIL is a good idea"
Zamorano-Carrillo, A
| | | | | | · Preparing the next pandemic: a view from bioethics
Gómez-Torrijos, C
| | | | | Originals | | | | | | · Quality control in neonatal parenteral nutrition, using biochemical analysis as a validated method
González-García, I; Fraile-Clemente, C; García-Bello, MA; Merino-Alonso, FJ
| | | | | | · Effectiveness and safety of panitumumab for metastatic colorectal cancer treatment
Monforte-Gasque, MP; Lázaro-Gallardo, EM; Maroto-García, E; Querol-Hernández, AC; Lázaro-Castellano, AM
| | | | | | · Inmune-related toxicity with pembrolizumab in health care practice
Talens-Bolós, A; Candela-Boix, MR; Bujaldón-Querejeta, N; Cercós-Lletí, AC
| | | | | | · Pharmaceutical Care Services in private community pharmacies in Costa Rica: user perception
Rojas-León, C; Segura-Cano, S; Lizano-Barrantes, C; Cordero-García, E
| | | | | | · Survey on the impact of the COVID-19 pandemic on the consumption of medicines, recreational drugs and alcoholic beverages in Argentina
Sciannameo, S; Zalazar, V; Aristegui, I; Parera, D; Sued, O
| | | | | | · Suspicion of suicides and hallucinations possibly due to hydroxychloroquine for the treatment of Coronavirus Disease 2019
Salguero-Olid, A; García-Marco, D; Rueda-Naharro, A; Martínez-Camacho, M; Espinosa-Rodríguez, A; González-del Valle, E
| | | | | | · Characteristics and results of patients admitted with COVID-19 during the pandemic
Sanz-Tamargo, G; Martí-Llorca, A; Boquera-Ferrer, M; Raga-Beser, A
| | | | | Special Article | | | | | | · The future of drug compounding: comments on the Real Decreto 175/2001 modification project
Pascual-Masiá, L; Martínez-Galán, F
| | | | | Reviews | | | | | | · International patient safety goals in the Primary Health Care: an integrative review
Pegoraro-Alves-Zarpelon, S; Piva-Klein, L; Bueno, D
| | | | | | · Evaluation instruments of peripheral neuropathy induced by chemotherapy in patients with multiple myeloma
Da Silva, AL; Figueiredo-Modesto, AC; Medrado-e Silva, PB; Cordeiro-de Farias, DL; Pandolfo-Provin, M; Almeida-Matteucci-Ferreira, TX
| | | | | Clinical Cases | | | | | | · Antidigoxin antibodies and renal failure: rebound toxicity. A case report
Repilado-Álvarez, A; Romero-López, R; Hernández-Terciado, F; Santiago-Prieto, E
| | | | | | · COVID-19 in a patient with spinal muscular atrophy: a case report
De La Calle-Riaguas, B; Casamayor-Lázar, B; Gómez-Espinosa, P; Berrocal-Javato, MA
| | | | | | · Management of high doses of methotrexate in a case of acute lymphoblastic leukemia
Alarcón-Payer, C; Muñoz-Cid, CL; Claramunt-García, R; Jiménez-Morales, A
| | | | | | · Multidisciplinary clinical management of complex patient with Crohn's disease and paradoxical psoriasiform reaction
Gil-Sierra, MD; Briceño-Casado, MP
| | | | | | · Tumor lysis syndrome in hematologic patient
Claramunt-García, R; Muñoz-Cid, CL; Sánchez-Ruiz, A
| | | | | | · Pharmacokinetics of dabigatran and use of its antidote idarucizumab
De Santiago-Álvarez, R; Hernández-Terciado, C; Delgado-Téllez-de Cepeda, L; Sánchez-Guerrero, A
| | | | | Letters to the Editor | | | | | | · Isoappearance and labeling in samples for clinical research: a safety problem
Torrano-Belmonte, P; Nájera-Pérez, MD; Fructuoso-González, L; Ibáñez-Caturla, J
| | | | | | · Pembrolizumab, fixed or weight-adjusted dose? Not a trivial decision
Gea-Navarrete, S; Montesinos-Ortí, S; Prieto-Castelló, M; Soler-Company, E
| | | |
|
All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License
pdf
